F293-0983 Screening compound: 5-[4-(propan-2-yl)benzenesulfonamido]-2-{3-[(pyrrolidin-1-yl)methyl]piperidin-1-yl}pyridine-3-carboxylic acid

F293-0983 Screening compound: 5-[4-(propan-2-yl)benzenesulfonamido]-2-{3-[(pyrrolidin-1-yl)methyl]piperidin-1-yl}pyridine-3-carboxylic acid
F293-0983 Screening compound: 5-[4-(propan-2-yl)benzenesulfonamido]-2-{3-[(pyrrolidin-1-yl)methyl]piperidin-1-yl}pyridine-3-carboxylic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound F293-0983
5-[4-(propan-2-yl)benzenesulfonamido]-2-{3-[(pyrrolidin-1-yl)methyl]piperidin-1-yl}pyridine-3-carboxylic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F293-0983

Molecular Formula

C25H34N4O4S (C25 H34 N4 O4 S)

Compound Name

5-[4-(propan-2-yl)benzenesulfonamido]-2-{3-[(pyrrolidin-1-yl)methyl]piperidin-1-yl}pyridine-3-carboxylic acid

IUPAC name

5-[4-(propan-2-yl)benzenesulfonamido]-2-{3-[(pyrrolidin-1-yl)methyl]piperidin-1-yl}pyridine-3-carboxylic acid

SMILES

CC(C)c(cc1)ccc1S(Nc(cc1C(O)=O)cnc1N1CC(CN2CCCC2)CCC1)(=O)=O

InChI

InChI=1S/C25H34N4O4S/c1-18(2)20-7-9-22(10-8-20)34(32,33)27-21-14-23(25(30)31)24(26-15-21)29-13-5-6-19(17-29)16-28-11-3-4-12-28/h7-10,14-15,18-19,27H,3-6,11-13,16-17H2,1-2H3,(H,30,31)/t19-/m1/s1

InChI Key

PONNJJHIKLFESH-LJQANCHMSA-N

MDL Number (MFCD)

MFCD27113022

Chemical and Physical Properties

Saltdata

CF3COOH

Molecular Weight

486.64

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.661

Distribution Coefficient, logD

4.661

Water Solubility, LogSw

-4.20

Polar Surface Area

85.851

Acid Dissociation Constant (pKa)

5.80

Base Dissociation Constant (pKb)

9.04

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

52.00

F293-0983 in Drug Discovery

Included in Screening Libraries

Eccentric PPI Library (11937 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PI3K-Targeted Library (17255 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

SH2 Library (10483 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Endocrine
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F293-0983 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F293-0983?
Check Price and Availability of F293-0983, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F293-0983 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F293-0983
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F293-0983
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F293-0983 available by request